Crohn's disease - The Lancet
4.5 (240) · $ 10.99 · In stock
Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study - The Lancet
Nutritional Management of Crohn's Disease - ppt download
Risankizumab safe and effective maintenance therapy for Crohn's Disease: Lancet
PDF) The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
PDF) Extraintestinal Manifestations and Intestinal Complications in Patients with Crohn's Disease: Associations with Some Clinico-Laboratory Findings, Immunological Markers and Therapy
Can Crohn's disease cause cancer? Prevalence and explanation
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease - The Lancet
Associated Conditions
What to eat with Crohn's Disease or Ulcerative Colitis
Carolina Altavilla - THE LANCET (UK) Part II
Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease
Associated Conditions
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial - ScienceDirect
Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data
Cureus Advancements in Inflammatory Bowel Disease: A Narrative
